Status:
RECRUITING
Screening of Malignant Hyperthermia Susceptible Individuals
Lead Sponsor:
Peking University Third Hospital
Conditions:
Malignant Hyperthermia
Eligibility:
All Genders
Up to 100 years
Brief Summary
This study intends to target patients who underwent surgery under general anesthesia during the study period and developed malignant hyperthermia during or after surgery. Therefore, the total sample s...
Eligibility Criteria
Inclusion
- Patients undergoing surgery under general anesthesia during the study period developed malignant hyperthermia during or after surgery.
Exclusion
- Malignant hyperthermia was ruled out by later treatment and diagnosis;
- The patient or family member refuses to be recruited.
Key Trial Info
Start Date :
February 22 2022
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
February 1 2041
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT05402839
Start Date
February 22 2022
End Date
February 1 2041
Last Update
June 2 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Peking University Third Hospital
Beijing, Beijing Municipality, China, 100191